Madam Speaker, November is diabetes month, and as the month draws to a close, I would like to say a few words, with less emotion than yesterday but just as much pride, in recognition of the exceptional work of Sherbrooke's own Dr. André Carpentier, who has become an international leader in diabetes research. He developed a series of molecular imaging methods to study how fats behave in the human body.
Dr. Carpentier and his team were the first to observe the thermogenesis of brown fat, and they are also the only team to have measured the metabolic breakdown of dietary fats. These advances will help develop drugs to treat certain complications associated with type 2 diabetes.
Dr. Carpentier is a professor of medicine and a physician-scientist at the Centre hospitalier universitaire de Sherbrooke, the CHUS, and he is also the director or co-director of several diabetes research networks. In addition, in December, Dr. Carpentier will become the new scientific director of the CHUS research centre.
My hearty congratulations to him for his excellent work and his involvement on so many levels.